ProMIS Neurosciences, Inc. (PMN)

NASDAQ: PMN · IEX Real-Time Price · USD
2.010
-0.090 (-4.29%)
Feb 26, 2024, 10:13 AM EST - Market open

ProMIS Neurosciences Income Statement

Millions USD. Fiscal year is Jan - Dec.
Year 202220212020
Selling, General & Admin
7.293.662.03
Research & Development
16.094.632.22
Operating Expenses
23.388.294.25
Operating Income
-23.38-8.29-4.25
Interest Expense / Income
0.280.420
Other Expense / Income
-5.61.08-0
Pretax Income
-18.06-9.79-4.25
Net Income
-18.06-9.79-4.25
Shares Outstanding (Basic)
865
Shares Outstanding (Diluted)
865
Shares Change
29.68%21.55%-
EPS (Basic)
-2.41-1.69-0.89
EPS (Diluted)
-2.41-1.69-0.89
Free Cash Flow
-17.04-9.21-3.31
Free Cash Flow Per Share
-2.27-1.59-0.70
EBITDA
-17.77-9.33-4.24
Depreciation & Amortization
0.010.050.01
EBIT
-17.78-9.37-4.25
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).